| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.02T | 1.01T | 712.72B | 587.98B | 503.63B | 483.83B |
| Gross Profit | 128.54B | 123.69B | 88.03B | 67.21B | 49.59B | 42.96B |
| EBITDA | 29.52B | 28.29B | 23.34B | 18.91B | 12.85B | 7.17B |
| Net Income | 9.05B | 8.54B | 8.46B | 7.87B | 6.72B | 1.86B |
Balance Sheet | ||||||
| Total Assets | 392.00B | 399.36B | 407.64B | 225.77B | 180.89B | 168.11B |
| Cash, Cash Equivalents and Short-Term Investments | 42.37B | 43.99B | 47.00B | 20.39B | 15.72B | 14.39B |
| Total Debt | 113.19B | 126.99B | 115.39B | 50.69B | 26.13B | 29.11B |
| Total Liabilities | 300.11B | 307.71B | 313.35B | 158.82B | 120.35B | 113.52B |
| Stockholders Equity | 89.32B | 89.16B | 90.46B | 64.43B | 58.02B | 52.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.58B | 9.06B | 2.63B | 2.66B | 1.33B |
| Operating Cash Flow | 0.00 | 25.93B | 23.94B | 13.75B | 8.32B | 5.17B |
| Investing Cash Flow | 0.00 | -18.98B | -36.81B | -22.05B | 833.00M | -2.19B |
| Financing Cash Flow | 0.00 | -8.38B | 38.18B | 12.62B | -7.95B | -10.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥93.08B | 15.98 | 6.89% | 1.68% | 7.50% | 107.15% | |
77 Outperform | ¥61.36B | 11.67 | 16.91% | 2.28% | 12.37% | 26.48% | |
75 Outperform | ¥58.27B | 10.50 | ― | 2.82% | -5.63% | 52.73% | |
73 Outperform | ¥108.77B | 10.14 | ― | 3.74% | -2.33% | -16.42% | |
72 Outperform | ¥82.94B | 3.93 | ― | 2.78% | 17.27% | -16.85% | |
68 Neutral | ¥103.48B | 9.91 | ― | 2.91% | 31.48% | 83.15% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |